ESC & iPSC News Volume 5.22 | Jun 9 2010

ESC & iPSC News 5.22, June 9, 2010.
In this issue:  Science News |  Current Publications |  Industry News |  Policy News |  Events
Subscribe  |  Unsubscribe


Scientists’ Finding of an Ancient Viral Invasion that Shaped the Human Genome an Important Step Towards Advancement in Regenerative Medicine
Scientists have discovered that viruses that ‘invaded’ the human genome millions of years ago have changed the way genes get turned on and off in human embryonic stem cells. [Press release from the Genome Institute of Singapore discussing online prepublication in Nature Genetics]




Stem Cells for First Time Used to Create Abnormal Heart Cells for Study of Cardiomyopathy
Researchers have, for the first time, differentiated human stem cells to become heart cells with cardiomyopathy. [Press release from ScienceDaily discussing online prepublication in Nature]

New Type of Human Stem Cell May Be Easier to Manipulate
Researchers have developed a new type of human pluripotent stem cell that can be manipulated more readily than currently available stem cells. [Press release from the Massachusetts General Hospital Center for Regenerative Medicine discussing online prepublication in Cell Stem Cell]

Gene Related to Aging Plays Role in Stem Cell Differentiation
A gene shown to play a role in the aging process appears to play a role in the regulation of the differentiation of embryonic stem cells. [Press release from Thomas Jefferson University Hospitals discussing online prepublication in Aging Cell]

Derive iPSCs feeder-free* with mTeSR®1
by STEMCELL Technologies
*Sun et al., PNAS, September 2009.
*Chan et al., Nature Biotechnology, October 2009.
STEMCELL Technologies Inc

CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

Patient-Specific Induced Pluripotent Stem-Cell-Derived Models of LEOPARD Syndrome
Researchers show that in vitro-derived cardiomyocytes from LEOPARD syndrome induced pluripotent stem cells (iPSCs) are larger, have a higher degree of sarcomeric organization and preferential localization of NFATC4 in the nucleus when compared with cardiomyocytes derived from human embryonic stem cells or wild-type iPSCs derived from a healthy brother of one of the LEOPARD syndrome patients. [Nature]

Transposable Elements Have Rewired the Core Regulatory Network of Human Embryonic Stem Cells
Data indicate that species-specific transposable elements have substantially altered the transcriptional circuitry of pluripotent stem cells. [Nat Genet]

A Murine ESC-Like State Facilitates Transgenesis and Homologous Recombination in Human Pluripotent Stem Cells
Researchers demonstrate that human induced pluripotent stem cell reprogramming in the presence of LIF yields human stem cells that display morphological, molecular, and functional properties of murine embryonic stem cells (ESCs). [Cell Stem Cell]

ESCs Require PRC2 to Direct the Successful Reprogramming of Differentiated Cells toward Pluripotency
To investigate whether polycomb-group proteins are required for establishing, rather than maintaining, the pluripotent state, researchers compared the ability of wild-type, polycomb repressive complex (PRC)1-, and PRC2-depleted embryonic stem cells (ESCs) to reprogram human lymphocytes. [Cell Stem Cell]

The Role of YAP Transcription Coactivator in Regulating Stem Cell Self-Renewal and Differentiation
Researchers report that yes-associated protein (YAP) is inactivated during embryonic stem cell differentiation, as indicated by decreased protein levels and increased phosphorylation. Consistently, YAP is elevated during induced pluripotent stem cell reprogramming. [Genes Dev]

Tracking Differentiating Neural Progenitors in Pluripotent Cultures Using MicroRNA-Regulated Lentiviral Vectors
Using the present strategy, it was possible to track progeny from murine embryonic stem (ES) cells, human ES cells, and induced pluripotent stem cells as they differentiated toward the neural lineage. [Proc Natl Acad Sci U S A]

A Role for the Werner Syndrome Protein in Epigenetic Inactivation of the Pluripotency Factor Oct4
The presented results reveal a novel function of the protein encoded by the WRN gene, WRNp, and demonstrate that WRNp controls a key step in pluripotent stem cell differentiation. [Aging Cell]

E-Cadherin-Mediated Cell-Cell Contact is Critical for Induced Pluripotent Stem Cell Generation
Results highlight the critical role of E-cadherin-mediated cell-cell contact in reprogramming and suggest new routes for more efficient induced pluripotent stem cell generation. [Stem Cells]

Generation of Human Induced Pluripotent Stem Cells Bearing an Anti-HIV Transgene by a Lentiviral Vector Carrying an Internal Murine Leukemia Virus Promoter
Data indicate that researchers’ chimeric lentiviral vector is a valuable tool for generation of induced pluripotent stem cells (iPSCs) and the combination with vectors encoding transgenes allows for rapid establishment of desired genetically engineered iPSC lines. [Hum Gene Ther]

Culture of Human Pluripotent Stem Cells Using Completely Defined Conditions on a Recombinant E-Cadherin Substratum
Human embryonic stem cells and human induced pluripotent stem cells were grown on plates coated with a fusion protein consisting of E-cadherin and the IgG Fc domain using mTeSR1 medium. [BMC Dev Biol]


University of Minnesota, Mayo Clinic Sign Research Pact with Karolinska
The University of Minnesota and Mayo Clinic, under the mantle of the Minnesota Partnership for Biotechnology and Medical Genomics, have formed a strategic research relationship with the Karolinska Institute of Stockholm, Sweden. Leaders of each institution signed memoranda of understanding to commit to the formal ongoing collaboration, called the Frontiers of Biomedical Research. [Mayo Clinic Press Release]

Lonza Announces Worldwide, Exclusive Licensing and Supply Agreements with California Stem Cell Inc.
Lonza Inc. has entered worldwide, exclusive licensing and supply agreements with California Stem Cell Inc. This collaboration makes novel pluripotent stem cell products readily available to researchers worldwide. [Lonza, Inc. Press Release]

International Stem Cell Corporation’s Parthenogenetic Stem Cell Patent is Approved by the United States Patent and Trademark Office
International Stem Cell Corporation announced that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic stem cells. [International Stem Cell Corporation Press Release]

ISSCR Launches Web Site Providing Information on Stem Cell Treatments
The International Society for Stem Cell Research (ISSCR) announced that it has launched “A Closer Look at Stem Cell Treatments” (, a Web site to arm patients, their families and doctors with information they need to make decisions about stem cell treatments. [International Society for Stem Cell Research Press Release]

GnuBio, a Harvard Spinout, Aims to Become an “eBay of Biomarkers”
GnuBio is a new Harvard University spinout that is poised to become an “eBay of Biomarkers,” according to founder John Boyce. The company is part genome sequencing, part database management, part social network. [Harvard School of Engineering and Applied Sciences Press Release]

The New York Stem Cell Foundation Awards Fellowships to Eight Innovative Stem Cell Scientists
The New York Stem Cell Foundation (NYSCF) announced the award of eight new NYSCF-Druckenmiller Fellows. [The New York Stem Cell Foundation Press Release]

Statement from the Stem Cell Institute Regarding Decision to Close Costa Rican Operations
The Stem Cell Institute announced that it proactively and independently made the business decision in early June to close its clinic and lab in Costa Rica and centralize all operations in Panama City, Panama. [PR Newswire]


Obama Nominates Suresh to Lead NSF
President Barack Obama has chosen Massachusetts Institute of Technology Engineering Dean Subra Suresh to be the next director of the National Science Foundation (NSF). [National Science Foundation, United States]

Treasury Releases New Guidance for Tax Credit in Affordable Care Act to Support Groundbreaking Biomedical Research
The U.S. Department of the Treasury announced the guidelines for applying for the new Therapeutic Discovery Project Program created by the Affordable Care Act. [Department of the Treasury, United States]

STAR METRICS: New Way to Measure the Impact of Federally Funded Research
A new initiative–Science and Technology for America’s Reinvestment: Measuring the Effect of Research on Innovation, Competitiveness and Science, or STAR METRICS–promises to monitor the impact of federal science investments on employment, knowledge generation, and health outcomes. [National Institutes of Health, United States]

Gene Test Hope for Personalized Cancer Therapy
National Health Service patients are to be offered personalized cancer treatment under a pilot scheme to carry out genetic tests on individuals’ tumors. [National Health Service, United Kingdom]

Final Report of The National Academies’ Human Embryonic Stem Cell Research Advisory Committee and 2010 Amendments to the National Academies’ Guidelines for Human Embryonic Stem Cell Research [National Academy of Sciences, United States]

2010 Biological License Application Approvals [Food and Drug Administration, United States]

2010 Biological Device Application Approvals [Food and Drug Administration, United States]


8th International Conference on Cell and Stem Cell Engineering (ICCE2010)
June 11-12, 2010
Dublin, Ireland

Tissue Engineering & Regenerative Medicine International Society (TERMIS) – European Union 2010
June 13-17, 2010
Galway, Ireland

Cedars-Sinai Regenerative Medicine Scientific Symposium
June 14, 2010
Los Angeles, United States

International Society for Stem Cell Research (ISSCR) 8th Annual Meeting
June 16-19, 2010
San Francisco, United States

United Kingdom National Stem Cell Network (UKNSCN) 3rd Annual Scientific Conference
July 12-14, 2010
Nottingham, United Kingdom

2nd International Conference on Cellular and Molecular Bioengineering (ICCMB2)
August 2-4, 2010

Select Biosciences 3rd Annual Stem Cells Europe Conference
August 24-25, 2010
Edinburgh, Scotland

Select Biosciences Inaugural Cellular Therapy Summit

August 24-25, 2010
Edinburgh, Scotland

International Society for Cellular Therapy (ISCT) – Europe 2nd Regional Meeting
September 11-14, 2010
Belgirate, Italy

Stem Cells USA & Regenerative Medicine Congress 2010
September 13-15, 2010
Philadelphia, United States

Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010
September 15-17, 2010
Sydney, Australia

5th World Congress on Preventive & Regenerative Medicine (WCRM) 2010
October 5-7, 2010
Hannover, Germany

Fraunhofer Life Science Symposium Leipzig 2010
October 29-30, 2010
Leipzig, Germany

Select Biosciences 2nd International Forum on Stem Cells
November 12-13, 2010
Tianjin, China

Stem Cell Network 10th Annual Scientific Meeting
November 22-24, 2010
Calgary, Canada

Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference
December 5-8, 2010
Orlando, United States

Stem Cells World Congress
January 24-25, 2011
San Diego, United States

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.



Senior Scientist – Magnetic Cell Separation (STEMCELL Technologies)

Business Development Manager Europe – Cell Therapy Products (Pall Corporation)

Manager/Sr. Manager, Therapeutic Cell Solutions, Process Development (Lonza)

Sr. Product Support and Training Specialist (CardianBCT)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with ESC & iPSC News.

Visit here to post your career opportunities.


 Learn more about ESC & iPSC News:  Archives |  Events |  Subscribe |  Contact Us